Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Giganti, Ph.D.

Concepts (171)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections322024173520.730 Why?
Antiretroviral Therapy, Highly Active12202418970.680 Why?
Anti-HIV Agents18202445270.670 Why?
Anti-Retroviral Agents6202217840.620 Why?
Epidemiologic Research Design120193680.530 Why?
Zambia1620122620.490 Why?
Statistics as Topic1202023580.460 Why?
Biostatistics120151640.430 Why?
Epidemiologic Methods2201513360.360 Why?
Hemoglobins2201215260.280 Why?
RNA, Viral6202328460.270 Why?
Pregnancy Complications, Infectious6202421510.270 Why?
Infectious Disease Transmission, Vertical5201313510.250 Why?
Viral Load4202433320.240 Why?
Zidovudine320246240.220 Why?
Anemia1201215090.210 Why?
Latin America420174100.200 Why?
CD4 Lymphocyte Count9201725710.200 Why?
Antibodies, Viral4202431560.180 Why?
Nevirapine220102730.160 Why?
Adult3620242212030.150 Why?
Observation120193100.150 Why?
Caribbean Region220151910.150 Why?
Stillbirth220113680.150 Why?
Public Health1201026690.140 Why?
Hospitalization32024107210.130 Why?
Adenine220119870.120 Why?
Antibodies, Monoclonal4202491770.120 Why?
Antiviral Agents5202430600.120 Why?
Cohort Studies112020414930.120 Why?
HIV-15201768630.110 Why?
Malnutrition220106450.110 Why?
Humans4820247615720.110 Why?
Premature Birth1202417820.100 Why?
Female3720243926860.100 Why?
Pregnancy122024298760.090 Why?
Developing Countries2201328850.090 Why?
Continuity of Patient Care1201710690.090 Why?
Infant Mortality220137590.080 Why?
Male2720243608420.080 Why?
Fetal Death120114350.080 Why?
Acquired Immunodeficiency Syndrome1201821990.080 Why?
Contraceptives, Oral, Hormonal120091900.080 Why?
Safety1201211500.070 Why?
Child Health Services120136460.070 Why?
Treatment Outcome112024646840.070 Why?
Young Adult102024592550.070 Why?
Prenatal Care2201111390.070 Why?
Software1202044340.070 Why?
Health Knowledge, Attitudes, Practice2201240160.070 Why?
Health Education1201210520.060 Why?
Africa320137090.060 Why?
Proportional Hazards Models62016124630.060 Why?
Age Distribution1201028800.060 Why?
Inflammation12024107730.060 Why?
Antibodies, Neutralizing2202419430.060 Why?
Adolescent92017883240.050 Why?
Middle Aged1320242209200.050 Why?
RNA2202327260.050 Why?
Infant, Newborn62013261980.050 Why?
Survival Analysis22012100900.050 Why?
Half-Life120236510.050 Why?
Child, Preschool62022422300.050 Why?
Urban Population1201020360.050 Why?
Respiratory Tract Infections1200910100.050 Why?
Data Collection1201033220.050 Why?
Honduras12020370.040 Why?
Biological Assay120236260.040 Why?
Rural Population1201122850.040 Why?
Cause of Death1201136830.040 Why?
Pregnancy Outcome1201129220.040 Why?
Infant62013361920.040 Why?
Weight Gain1201023480.040 Why?
Argentina120202460.040 Why?
Chile120202560.040 Why?
Models, Biological2201394690.040 Why?
Drug Therapy, Combination2202463120.040 Why?
Drug Resistance, Viral120248620.040 Why?
Double-Blind Method22023123410.040 Why?
Retrospective Studies102022806460.040 Why?
Cross-Sectional Studies42017261270.040 Why?
Drug Combinations1202420480.040 Why?
Child72022801560.040 Why?
Viremia120217070.040 Why?
Urban Health220115320.040 Why?
Mexico120207640.040 Why?
CD4-Positive T-Lymphocytes1200943690.030 Why?
Outpatients1202415970.030 Why?
Pneumonia, Pneumocystis120182420.030 Why?
Brazil1202012300.030 Why?
Sex Characteristics1200626390.030 Why?
South America120161790.030 Why?
Kinetics1202363740.030 Why?
Phosphoproteins1202424480.030 Why?
Time Factors42023399700.030 Why?
Aging2202087110.030 Why?
Aged520241693100.030 Why?
Program Evaluation2201324950.030 Why?
Electronic Health Records1201148110.030 Why?
Primary Health Care1201046860.030 Why?
Age Factors32018183980.030 Why?
Grenada1201230.030 Why?
Drowning12012260.030 Why?
Disease Progression12009135100.030 Why?
North America1201612760.030 Why?
Gestational Age2201135770.030 Why?
Algorithms12013140320.030 Why?
Predictive Value of Tests32013152660.020 Why?
Liver Diseases1202012980.020 Why?
Immunoglobulin G1202345440.020 Why?
Canada1201621220.020 Why?
Lymphoma, Non-Hodgkin1201813740.020 Why?
Faculty120123840.020 Why?
Area Under Curve1201316380.020 Why?
Multivariate Analysis22013120590.020 Why?
Perinatal Care120112430.020 Why?
Syphilis120112430.020 Why?
Family Characteristics1201310040.020 Why?
Asia120096190.020 Why?
Early Diagnosis1201311860.020 Why?
Maternal Health Services120134610.020 Why?
Follow-Up Studies22022391070.020 Why?
Autopsy1201110090.020 Why?
Primates120095230.020 Why?
Risk Factors52013742130.020 Why?
Reverse Transcriptase Inhibitors120106210.020 Why?
Drugs, Generic120124480.020 Why?
Odds Ratio2201196460.020 Why?
Logistic Models22011132550.020 Why?
DNA, Viral1201322020.020 Why?
Renal Insufficiency, Chronic1202022430.020 Why?
Case-Control Studies12024221760.020 Why?
Water1201214110.020 Why?
HIV1201315820.020 Why?
Health Care Surveys1201324260.020 Why?
Health Status Indicators120119700.020 Why?
Health Services Research1201318120.020 Why?
Seroepidemiologic Studies120063970.020 Why?
Tuberculosis1201820170.010 Why?
Analysis of Variance1201362280.010 Why?
Treatment Failure1201026440.010 Why?
Medical Records1200914080.010 Why?
Educational Status1201125220.010 Why?
Polymerase Chain Reaction1201360750.010 Why?
Schools1201214890.010 Why?
Fetal Blood1201013470.010 Why?
Prevalence12020157320.010 Why?
Quality Indicators, Health Care1201317920.010 Why?
Birth Weight1201121030.010 Why?
Disease-Free Survival1201368150.010 Why?
Mothers1201321980.010 Why?
Drug Administration Schedule1201048530.010 Why?
Regression Analysis1201163440.010 Why?
Diabetes Mellitus1202058410.010 Why?
Mental Disorders1202068450.010 Why?
Feasibility Studies1201152470.010 Why?
India1200623480.010 Why?
Population Surveillance1201025980.010 Why?
Cost-Benefit Analysis1201254920.010 Why?
Socioeconomic Factors1201378270.010 Why?
Research Design1201361800.010 Why?
Health Services Accessibility1201354400.010 Why?
Mass Screening1201154280.010 Why?
Delivery of Health Care1201253360.010 Why?
Reproducibility of Results12013200990.010 Why?
Cardiovascular Diseases12020155010.010 Why?
Body Mass Index12010129540.010 Why?
Prognosis12013296290.010 Why?
Neoplasms12020221730.010 Why?
United States12016723350.000 Why?
Animals120091684670.000 Why?
Giganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (171)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.